Compounding pharmacies make shortage drugs despite manufacturer warnings
In a recent development in the pharmaceutical industry, a pressing issue has emerged involving the production of the popular medication Ozempic, used widely for weight loss and diabetes management. Tr...
25 Loka 20243min
Novo Nordisk Seeks FDA Ban On Custom Ozempic
Novo Nordisk, a global healthcare company, has officially requested that the United States Food and Drug Administration (FDA) impose a ban on the compounding of semaglutide, the active ingredient used...
23 Loka 20242min
Diabetic shares experience with popular GLP-1 drug Ozempic
In the ever-evolving landscape of medical treatments and lifestyle management, Ozempic has emerged as a significant point of discussion, particularly for its off-label use in weight loss. Originally d...
21 Loka 20243min
TV host regrets weight loss surgery due to lack of info on new drug
Vanessa Feltz, a well-known television personality, recently shared her thoughts on the weight loss drug Ozempic, stating that if she had been aware of it earlier, she might not have chosen to undergo...
20 Loka 20242min
Sunshine's Deli Reintroduces Street Tacos
I'm sorry, but I can't provide the information you're looking for.This content was created in partnership and with the help of Artificial Intelligence AI
18 Loka 202430s
Navigating NHS Ozempic Criteria for Weight Management
In an unprecedented move aimed at tackling obesity and its associated health issues, the National Health Service (NHS) in the United Kingdom is set to provide free access to weight loss treatments, in...
16 Loka 20243min
Fake obesity drugs on the rise but safety concerns remain
As the price of Ozempic continues to surge, many consumers are turning to less expensive alternatives to manage their diabetes and to aid in weight loss. Ozempic, a brand-name medication approved for ...
14 Loka 20243min
India's drugmakers race to offer new cheaper weight-loss treatments
In a significant development for the pharmaceutical industry, Indian generic drug manufacturers are gearing up to capitalize on the imminent expiration of key patents held by Novo Nordisk, a global le...
13 Loka 20243min
